FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1982-1989

  Ding, Yitian ^a   Wilkinson, Andrew ^a   Idris, Adi ^a   Fancke, Ben ^b,c   O'Keeffe, Meredith ^b,c   Khalil, Dalia ^a   Ju, Xinsheng ^a   Lahoud, Mireille H ^b,c   Caminschi, Irina ^b,d   Shortman, Ken ^b,d,e   Rodwell, Robyn ^f   Vuckovic, Slavica ^a,g,h   Radford, Kristen J ^a,g  

^a TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f MATER HOSPITAL   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN LIKE RECEPTOR 9A; CD1C ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; FLT3 LIGAND; INTERFERON; INTERFERON LAMBDA; INTERLEUKIN 12P70; LECTIN RECEPTOR; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN CADM1; PROTEIN XCR1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; BONE MARROW CELL; CD141+ DENDRITIC CELL; CD1C+ DENDRITIC CELL; CD8+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELL FUNCTION; CELL SUBPOPULATION; CONTROLLED STUDY; DENDRITIC CELL; FEASIBILITY STUDY; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; TARGET CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, SURFACE; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; INTERFERON-GAMMA; INTERLEUKIN-12; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; POLY I-C; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 84896724294     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302391     Document Type: Article

References (40)

1. Hildner, K., B. T. Edelson, W. E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B. U. Schraml, E. R. Unanue, M. S. Diamond, et al. 2008. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
2. Radford, K. J., and I. Caminschi. 2013. New generation of dendritic cell vaccines. Hum. Vaccin. Immunother. 9: 9.
3. Bachem, A., S. Güttler, E. Hartung, F. Ebstein, M. Schaefer, A. Tannert, A. Salama, K. Movassaghi, C. Opitz, H. W. Mages, et al. 2010. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207: 1273-1281.
4. Crozat, K., R. Guiton, V. Contreras, V. Feuillet, C. A. Dutertre, E. Ventre, T. P. Vu Manh, T. Baranek, A. K. Storset, J. Marvel, et al. 2010. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207: 1283-1292.
5. Haniffa, M., A. Shin, V. Bigley, N. McGovern, P. Teo, P. See, P. S. Wasan, X. N. Wang, F. Malinarich, B. Malleret, et al. 2012. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37: 60-73.
6. Jongbloed, S. L., A. J. Kassianos, K. J. McDonald, G. J. Clark, X. Ju, C. E. Angel, C. J. Chen, P. R. Dunbar, R. B. Wadley, V. Jeet, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207: 1247-1260.
7. Poulin, L. F., M. Salio, E. Griessinger, F. Anjos-Afonso, L. Craciun, J. L. Chen, A. M. Keller, O. Joffre, S. Zelenay, E. Nye, et al. 2010. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 207: 1261-1271.
8. Caminschi, I., A. I. Proietto, F. Ahmet, S. Kitsoulis, J. Shin Teh, J. C. Lo, A. Rizzitelli, L. Wu, D. Vremec, S. L. van Dommelen, et al. 2008. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112: 3264-3273.
9. Crozat, K., S. Tamoutounour, T. P. Vu Manh, E. Fossum, H. Luche, L. Ardouin, M. Guilliams, H. Azukizawa, B. Bogen, B. Malissen, et al. 2011. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J. Immunol. 187: 4411-4415.
10. Galibert, L., G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. 2005. Nectinlike protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280: 21955-21964.
11. Huysamen, C., J. A. Willment, K. M. Dennehy, and G. D. Brown. 2008. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 283: 16693-16701.
12. Poulin, L. F., Y. Reyal, H. Uronen-Hansson, B. U. Schraml, D. Sancho, K. M. Murphy, U. K. Håkansson, L. F. Moita, W. W. Agace, D. Bonnet, and C. Reis e Sousa. 2012. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 119: 6052-6062.
13. Sancho, D., D. Mourão-Sá, O. P. Joffre, O. Schulz, N. C. Rogers, D. J. Pennington, J. R. Carlyle, and C. Reis e Sousa. 2008. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 118: 2098-2110.
14. Lauterbach, H., B. Bathke, S. Gilles, C. Traidl-Hoffmann, C. A. Luber, G. Fejer, M. A. Freudenberg, G. M. Davey, D. Vremec, A. Kallies, et al. 2010. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 207: 2703-2717.
15. Cohn, L., B. Chatterjee, F. Esselborn, A. Smed-Sörensen, N. Nakamura, C. Chalouni, B. C. Lee, R. Vandlen, T. Keler, P. Lauer, et al. 2013. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J. Exp. Med. 210: 1049-1063.
16. Hoeffel, G., A. C. Ripoche, D. Matheoud, M. Nascimbeni, N. Escriou, P. Lebon, F. Heshmati, J. G. Guillet, M. Gannagé, S. Caillat-Zucman, et al. 2007. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27: 481-492.
17. Mittag, D., A. I. Proietto, T. Loudovaris, S. I. Mannering, D. Vremec, K. Shortman, L. Wu, and L. C. Harrison. 2011. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J. Immunol. 186: 6207-6217.
18. Segura, E., M. Durand, and S. Amigorena. 2013. Similar antigen crosspresentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J. Exp. Med. 210: 1035-1047.
19. Kassianos, A. J., M. Y. Hardy, X. Ju, D. Vijayan, Y. Ding, A. J. Vulink, K. J. McDonald, S. L. Jongbloed, R. B. Wadley, C. Wells, et al. 2012. Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immunoregulatory phenotype and function in response to Escherichia coli. Eur. J. Immunol. 42: 1512-1522.
20. Kassianos, A. J., S. L. Jongbloed, D. N. Hart, and K. J. Radford. 2010. Isolation of human blood DC subtypes. Methods Mol. Biol. 595: 45-54.
21. Shultz, L. D., M. A. Brehm, J. V. Garcia-Martinez, and D. L. Greiner. 2012. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 12: 786-798.
22. Rathinam, C., W. T. Poueymirou, J. Rojas, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, A. Rongvaux, E. E. Eynon, M. G. Manz, and R. A. Flavell. 2011. Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood 118: 3119-3128.
23. Chen, Q., F. He, J. Kwang, J. K. Chan, and J. Chen. 2012. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J. Immunol. 189: 5223-5229.
24. Rongvaux, A., T. Willinger, H. Takizawa, C. Rathinam, W. Auerbach, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, E. E. Eynon, S. Stevens, et al. 2011. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc. Natl. Acad. Sci. USA 108: 2378-2383.
25. Willinger, T., A. Rongvaux, H. Takizawa, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, W. Auerbach, E. E. Eynon, S. Stevens, M. G. Manz, and R. A. Flavell. 2011. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. USA 108: 2390-2395.
26. Chen, Q., M. Khoury, and J. Chen. 2009. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc. Natl. Acad. Sci. USA 106: 21783-21788.
27. Smith, M. S., D. C. Goldman, A. S. Bailey, D. L. Pfaffle, C. N. Kreklywich, D. B. Spencer, F. A. Othieno, D. N. Streblow, J. V. Garcia, W. H. Fleming, and J. A. Nelson. 2010. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8: 284-291.
28. Palucka, A. K., J. Gatlin, J. P. Blanck, M. W. Melkus, S. Clayton, H. Ueno, E. T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, et al. 2003. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 102: 3302-3310.
29. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J. C. Piffaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
30. Vuckovic, S., F. S. Abdul Wahid, A. Rice, M. Kato, D. Khalil, R. Rodwell, and D. N. Hart. 2008. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells. Exp. Hematol. 36: 1496-1506.
31. Cravens, P. D., M. W. Melkus, A. Padgett-Thomas, M. Islas-Ohlmayer, M. Del P Martin, and J. V. Garcia. 2005. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells 23: 264-278.
32. Maraskovsky, E., E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack, and H. J. McKenna. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96: 878-884.
33. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165: 566-572.
34. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122-2130.
35. Kato, M., K. J. McDonald, S. Khan, I. L. Ross, S. Vuckovic, K. Chen, D. Munster, K. P. MacDonald, and D. N. Hart. 2006. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int. Immunol. 18: 857-869.
36. Chen, W., A. S. Chan, A. J. Dawson, X. Liang, B. R. Blazar, and J. S. Miller. 2005. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function. Biol. Blood Marrow Transplant. 11: 23-34.
37. MacDonald, K. P., D. J. Munster, G. J. Clark, A. Dzionek, J. Schmitz, and D. N. Hart. 2002. Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520.
38. Meixlsperger, S., C. S. Leung, P. C. Rämer, M. Pack, L. D. Vanoaica, G. Breton, S. Pascolo, A. M. Salazar, A. Dzionek, J. Schmitz, et al. 2013. CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 121: 5034-5044.
39. Tanaka, S., Y. Saito, J. Kunisawa, Y. Kurashima, T. Wake, N. Suzuki, L. D. Shultz, H. Kiyono, and F. Ishikawa. 2012. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rgKO mice. J. Immunol. 188: 6145-6155.
40. Yu, C. I., C. Becker, Y. Wang, F. Marches, J. Helft, M. Leboeuf, E. Anguiano, S. Pourpe, K. Goller, V. Pascual, et al. 2013. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β. Immunity 38: 818-830.